# Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose

> **NCT01173302** · PHASE4 · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 160 (estimated)

## Conditions studied

- Rabies

## Interventions

- **BIOLOGICAL:** Rabies vaccine, manufactured by ChengDa

## Key facts

- **NCT ID:** NCT01173302
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2010-08
- **Final completion:** 2010-09
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2010-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01173302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01173302, "Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01173302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*